![Dawn Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dawn Bell
Direttore/Membro del Consiglio presso STRM.Bio, Inc.
Profilo
Dawn Bell is currently working as a Director at STRM.Bio, Inc. She obtained a doctorate degree from the University of Florida.
Posizioni attive di Dawn Bell
Società | Posizione | Inizio |
---|---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Direttore/Membro del Consiglio | 17/05/2023 |
Formazione di Dawn Bell
University of Florida | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |
- Borsa valori
- Insiders
- Dawn Bell